Donahue Kevin Michael
SEC Form 4 insider trading activity
Donahue Kevin Michael has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jan 20, 2026.
On the most recent filing, Donahue Kevin Michael is listed as 10% Owner at MAINZ BIOMED N.V. Inside the rolling window, Donahue Kevin Michael reported 1 open-market purchase totaling $258.8B in MYNZ and no open-market sales.
Companies traded
Other insiders at MYNZ
Insider Buying
$258.8B
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Donahue Kevin Michael made?
Donahue Kevin Michael has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Donahue Kevin Michael trade?
Donahue Kevin Michael has filed SEC Form 4 disclosures for 1 company, including MYNZ.
When was Donahue Kevin Michael's most recent SEC Form 4 filing?
Donahue Kevin Michael's most recent SEC Form 4 filing on Tracefour is dated Jan 20, 2026.
What is Donahue Kevin Michael's total buy and sell value in the current window?
Inside the rolling retention window, Donahue Kevin Michael bought $258.8B and sold $0 based on SEC Form 4 filings.
What was Donahue Kevin Michael's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,328,850 MYNZ shares on 2025-10-17, worth $258.8B, per SEC Form 4 filings.